A genomic classifier predicting metastatic disease progression in men with biochemical recurrence after prostatectomy
about
Incorporation of tissue-based genomic biomarkers into localized prostate cancer clinicsWhat is the Need for Prostatic Biomarkers in Prostate Cancer Management?Loss of tumor suppressor mir-203 mediates overexpression of LIM and SH3 Protein 1 (LASP1) in high-risk prostate cancer thereby increasing cell proliferation and migration.Evolving transcriptomic fingerprint based on genome-wide data as prognostic tools in prostate cancerCombined value of validated clinical and genomic risk stratification tools for predicting prostate cancer mortality in a high-risk prostatectomy cohortEffect of a genomic classifier test on clinical practice decisions for patients with high-risk prostate cancer after surgeryHOXB13 overexpression is an independent predictor of early PSA recurrence in prostate cancer treated by radical prostatectomyA 22 Gene-expression Assay, Decipher® (GenomeDx Biosciences) to Predict Five-year Risk of Metastatic Prostate Cancer in Men Treated with Radical ProstatectomyRNA biomarkers associated with metastatic progression in prostate cancer: a multi-institutional high-throughput analysis of SChLAP1.RNA biomarkers to facilitate the identification of aggressive prostate cancerEvaluation of a genomic classifier in radical prostatectomy patients with lymph node metastasisClinically available RNA profiling tests of prostate tumors: utility and comparisonHigh Dimensional Variable Selection with Error ControlDecipher correlation patterns post prostatectomy: initial experience from 2 342 prospective patients.Biomarkers for prostate cancer: present challenges and future opportunities.Epigenomic Regulation of Androgen Receptor Signaling: Potential Role in Prostate Cancer Therapy.Commercialized biomarkers: new horizons in prostate cancer diagnostics.Which, when and why? Rational use of tissue-based molecular testing in localized prostate cancer.Multidisciplinary intervention of early, lethal metastatic prostate cancer: Report from the 2015 Coffey-Holden Prostate Cancer Academy Meeting.Clinical Utility of Biomarkers in Localized Prostate Cancer.Validation of a Genomic Risk Classifier to Predict Prostate Cancer-specific Mortality in Men with Adverse Pathologic Features.High concordance of findings obtained from transgluteal magnetic resonance imaging - and transrectal ultrasonography-guided biopsy as compared with prostatectomy specimens.NUSAP1 expression is upregulated by loss of RB1 in prostate cancer cells.Risk stratification of prostate cancer 2016.Genomic tests to guide prostate cancer management following diagnosis.p16 upregulation is linked to poor prognosis in ERG negative prostate cancer.Application of a Clinical Whole-Transcriptome Assay for Staging and Prognosis of Prostate Cancer Diagnosed in Needle Core Biopsy SpecimensGene expression signature of Gleason score is associated with prostate cancer outcomes in a radical prostatectomy cohort.Subclassification of high-risk clinically organ-confined prostate cancer for early cancer-specific mortality after radical prostatectomy.Decipher test impacts decision making among patients considering adjuvant and salvage treatment after radical prostatectomy: Interim results from the Multicenter Prospective PRO-IMPACT study.NUSAP1 promotes invasion and metastasis of prostate cancerProstate cancer radiomics and the promise of radiogenomics.Tissue-based biomarkers in prostate cancer.Up-regulation of mismatch repair genes MSH6, PMS2 and MLH1 parallels development of genetic instability and is linked to tumor aggressiveness and early PSA recurrence in prostate cancer.Clinical and genomic analysis of metastatic prostate cancer progression with a background of postoperative biochemical recurrence.[Molecular biomarkers and prognostic factors for prostate cancer].Robust genomic copy number predictor of pan cancer metastasis.
P2860
Q26752510-45F22947-1016-41E4-B85D-49745C8FF86BQ26798425-A2BE3DF5-DACD-4385-894A-8F11BC8A7B3BQ30009388-D20304E8-8627-4E71-ACCD-3920860DDAA6Q30938412-F8D80082-12CF-4ED7-B1CA-B0517F5FB226Q34807402-00446149-9EB2-411B-BB25-155D690D1CE8Q35211723-6DEB466C-FA66-4C7C-BB10-5BFAA4E98328Q35828702-02FCB945-C5B1-4C9E-AA1D-A987CC754850Q35868145-358ADA95-539C-41C5-B7A1-F639EE55AE13Q36025180-8DC2198D-260A-42AC-9970-3A01A0341126Q36260364-90BBD729-747F-4E9B-8719-FDE431E8E141Q37070927-4A36793D-E60B-489B-ACAB-75661D9AC7ADQ37113181-A6DFD41E-EC8C-4EC7-82BB-5A43796F536BQ37212655-D7F0B32E-73A3-4DE7-8B44-A868450D045FQ37463713-603E7F1E-82BB-4E56-865F-73CC61AD21DDQ37474443-5ABB6B84-9261-4749-8373-1E9E246B8513Q37629548-7A52C44D-BA0A-45EF-8F7D-6F759906C17EQ38364797-2001B084-D9F4-4767-9872-AA1296F6D282Q38540198-1D84AFFE-FAF5-4726-B4A4-1782418573FCQ38610286-77B30C77-11F4-4441-AACE-AAA19FEE78E5Q38792354-143C43F6-1CA9-49E7-B5D6-45FB73B97AA4Q38841717-9FAE6464-7F88-41A3-BD59-5370BD138011Q38906488-222A1686-2B22-4F6F-A814-820FC792E398Q38920403-346009D0-CBE8-43CB-9EE8-8B51B2AF1DE2Q38929868-967C10E6-181D-4809-A3D8-3312DC581C74Q39170943-6339FF9B-8C13-4119-AE94-F3282C6D0F7DQ39574305-CF5812E3-C42A-4CD5-B02F-1BAE7D8B5239Q39946238-0471FB30-D66E-402D-9909-EF978435339CQ40204742-D01581A8-A651-4C07-A1CB-CC5EC782E15BQ40743419-4A4F1160-D599-4C3F-83FF-44451C68B0DEQ41540713-E14EBF1D-A18B-44C3-9B56-984FEB8C72ACQ42244850-A16FBC89-3669-4468-8064-7F998CE2E6D0Q47135421-A50E5A3D-2D9E-46D4-A1D1-E0E6FDE67D8FQ47144748-7B18E07E-260C-43FA-84B6-D887D55602BEQ51350568-A7BE1CD8-9ACE-44F2-8310-32A900C73A0AQ52959809-CC8C100A-01EB-452B-897E-8BBC7ABBFB98Q53251387-65AAF102-5482-49A1-B555-5FFBB71DBB26Q55220545-04546454-C997-4661-BF28-BB697847584A
P2860
A genomic classifier predicting metastatic disease progression in men with biochemical recurrence after prostatectomy
description
2013 nî lūn-bûn
@nan
2013 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
A genomic classifier predictin ...... recurrence after prostatectomy
@ast
A genomic classifier predictin ...... recurrence after prostatectomy
@en
type
label
A genomic classifier predictin ...... recurrence after prostatectomy
@ast
A genomic classifier predictin ...... recurrence after prostatectomy
@en
prefLabel
A genomic classifier predictin ...... recurrence after prostatectomy
@ast
A genomic classifier predictin ...... recurrence after prostatectomy
@en
P2093
P2860
P356
P1476
A genomic classifier predictin ...... recurrence after prostatectomy
@en
P2093
D J S Thompson
E J Bergstralh
E M Schaeffer
I A Vergara
M Ghadessi
P2860
P2888
P356
10.1038/PCAN.2013.49
P577
2013-10-22T00:00:00Z